Vaccines are an important part of creating “herd immunity” to keep infectious diseases in check. Here are three vaccine developments that have far reaching implications for public health.
Gwen Nichols, MD, chief medical officer of the Leukemia & Lymphoma Society, offers a quick overview of current developments as well as a look forward.
Have two minutes? Listen to this quick podcast for critical takeaways from three of our top articles.
Payers are stepping up efforts to manage the cost and utilization of orphan drug treatments.
The cost to treat cancer in the United States could reach $156 billion in 2020, according to the National Cancer Institute. And innovative medications have a significant impact on the cost of care.
Expiring patents and biosimilar developments are creating big market opportunities within the specialty drug space.
In partnership with the several big-name cancer centers, one company has commenced clinical trials. Find out how this cancer vaccine would work.
More targeted therapies for autoimmune diseases are on the horizon. Here’s what to anticipate in 2018.
Prepare for major pipeline developments in diabetes, autoimmune disorders, oncology, and COPD.
Autologous stem cell therapy may offer hope for patients with COPD. But some say caution is necessary.